GE Ventures

Devices & Diagnostics

BSX gets FDA approval for ablation catheter, becomes third major player this week with ablation milestone

Boston Scientific (BSX) announced it has received U.S. Food and Drug Administration approval for its IntellaTip MiFi XP catheter and 501(k) clearance for its Zurpaz 8.5F steerable sheath, growing its EP mapping/ablation technology portfolio. This makes it the third major player–following both St. Jude Medical, which acquired Endosense, and GE, which invested in Acutus Medical–to […]

presented by
Channel

Medtech investors explain the nuances of evaluating reimbursement risk

It’s not as simple as “Do I have a code?” A “early stage vs. late stage” panel at today’s MedTech Investing conference in Minneapolis talked about what questions they ask when determining whether payers will reimburse new products and services. Investors have to consider multiple definitions of “value,” out-of-pocket possibilities, and the possibility of shifting […]